Proceedings of the ASNC cardiac PET summit meeting, May 12 2014, Baltimore MD: 4. Novel applications of cardiovascular PET

Journal of Nuclear Cardiology

Volumn 22, Issue 4, 2015, Pages 720-729

  Blankstein, Ron ^a   Lundbye, Justin ^b   Heller, Gary ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NEW BRITAIN GENERAL HOSPITAL   (United States)

^c Gagnon Cardiovascular Institute   (United States)

Author keywords

Fluorine 18; inflammation; metabolism: PET; PET imaging; vulnerable atherosclerotic plaque

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CANCER PATIENT; CARDIAC IMPLANT; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR SYSTEM EXAMINATION; CORONARY ARTERY BLOOD FLOW; DEFIBRILLATOR; DEVICE INFECTION; DUAL CHAMBER PACEMAKER; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART VALVE PROSTHESIS; HUMAN; INFECTION; PACEMAKER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROSTHETIC VALVE ENDOCARDITIS; SARCOIDOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT RESPONSE; VASCULITIS; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; PROCEDURES; REPRODUCIBILITY; RISK ASSESSMENT; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

CARDIOVASCULAR DISEASES; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84939463980     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-015-0210-8     Document Type: Article

References (24)

1. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy, CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1305-23.
2. Kandolin R, Lehtonen J, Graner M, Schildt J, Salmenkivi K, Kivisto SM, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med 2011;270:461-8.
3. Greulich S, Deluigi CC, Gloekler S, Wahl A, Zürn C, Kramer U, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC: Cardiovasc Imaging 2013;6:501-11.
4. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009;120:1969-77.
5. Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 2014;63:329-36.
6. Morooka M, Moroi M, Uno K, Ito K, Wu J, Nakagawa T, et al. Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis. EJNMMI Res 2014;4:1.
7. Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin F, Champagne J, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol 2012;59:1616-25.
8. Osborne M, Kolli S, Padera RF, Naya M, Lewis E, Dorbala S, et al. Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation. J Nucl Cardiol 2013;20:310-2.
9. Ahmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M, et al. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol 2014;21:925-39.
10. Betensky BP, Tschabrunn CM, Zado ES, Goldberg LR, Marchlinski FE, Garcia FC, et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm 2012;9:884-91.
11. Schuller JL, Zipse M, Crawford T, Bogun F, Beshai J, Patel AR, et al. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol 2012;23:925-9.
12. Waller AH, Blankstein R. Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis. J Nucl Cardiol 2014;21:940-3.
13. Osborne MT, Hulten EA, Singh A, Waller AH, Bittencourt MS, Stewart GC, et al. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol 2014;21:166-74.
14. Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: Increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol 2013;61:2374-82.
15. 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study. Eur J Nucl Med Mol Imaging 2014;41:1617-23.
16. Spacek M, Belohlavek O, Votrubova J, Sebesta P, Stadler P. Diagnostics of “non-acute” vascular prosthesis infection using 18F-FDG PET/CT: Our experience with 96 prostheses. Eur J Nucl Med Mol Imaging 2009;36:850-8.
17. Hartlage GR, Palios J, Barron BJ, Stillman AE, Bossone E, Clements SD, et al. Multimodality imaging of aortitis. JACC. Cardiovasc Imaging 2014;7:605-19.
18. Einspieler I, Thurmel K, Eiber M, Essler M. First experience of imaging large vessel vasculitis with fully integrated positron emission tomography/MRI. Circ Cardiovasc Imaging 2013;6:1117-9.
19. Treglia G, Mattoli MV, Leccisotti L, Ferraccioli G, Giordano A. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: A systematic review. Clin Rheumatol 2011;30:1265-75.
20. Bittencourt MS, Hulten E, Ghoshhajra B, O'Leary D, Christman MP, Montana P, et al. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ Cardiovasc Imaging 2014;7:282-91.
21. Braunwald E. Noninvasive detection of vulnerable coronary plaques: Locking the barn door before the horse is stolen. J Am Coll Cardiol 2009;54:58-9.
22. Nadra I, Mason JC, Philippidis P, Florey O, Smythe CD, McCarthy GM, et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: A vicious cycle of inflammation and arterial calcification? Circ Res 2005;96:1248-56.
23. Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 2014;383:705-13.
24. Thomas GS, Haraszti RA. A new frontier in atherosclerotic coronary imaging. Lancet 2014;383:674-5.